peritoneal mesothelioma (Cancer)
Information
- Disease name
- peritoneal mesothelioma
- Disease ID
- DOID:1788
- Description
- "A peritoneum cancer that develops from cells of the mesothelium and is located_in the peritoneum." [url:http\://en.wikipedia.org/wiki/Mesothelioma]
Disease area statistics
Chromosome band
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03867578 | Active, not recruiting | N/A | Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma | October 10, 2018 | January 22, 2025 |
| NCT02834234 | Completed | Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays | May 2013 | January 2016 | |
| NCT02040142 | Completed | Phase 2 | Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | November 2011 | November 9, 2020 |
| NCT01160458 | Completed | Phase 2 | Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy | June 2, 2010 | February 24, 2017 |
| NCT05041062 | Completed | Phase 2 | A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma | December 1, 2021 | April 13, 2023 |
| NCT06057935 | Recruiting | Phase 2 | A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma | September 21, 2023 | September 21, 2028 |
| NCT01617382 | Recruiting | Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed | May 2012 | December 2026 | |
| NCT03875144 | Recruiting | Phase 2 | Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) | August 14, 2020 | September 2028 |
| NCT04847063 | Recruiting | Phase 1 | Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies | October 19, 2021 | December 30, 2031 |
| NCT05337735 | Suspended | Phase 2 | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers | August 5, 2022 | April 1, 2025 |
| NCT03608618 | Terminated | Phase 1 | Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma | August 27, 2018 | August 24, 2021 |
| NCT02588131 | Unknown status | Phase 2 | A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) | October 2015 | March 2018 |
| NCT02834169 | Unknown status | French National Registry of Rare Peritoneal Surface Malignancies | October 2010 | December 2018 |
- Disase is a (Disease Ontology)
- DOID:1725
- Cross Reference ID (Disease Ontology)
- ICD10CM:C45.1
- Cross Reference ID (Disease Ontology)
- NCI:C8704
- Cross Reference ID (Disease Ontology)
- NCI:C9350
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:187806007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0346109
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0854886
- Exact Synonym (Disease Ontology)
- Advanced malignant Mesothelioma of Peritoneum
- Exact Synonym (Disease Ontology)
- advanced malignant peritoneal mesothelioma
- Exact Synonym (Disease Ontology)
- malignant mesothelioma of peritoneum
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100003